BioCardia(BCDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BCDA BioCardia

Post-Mkt 09-11 16:45:14 EDT

1.08

-0.02

-1.82%

盘后1.06

-0.02-1.85%

16:30 EDT

High1.14	Low1.08	Vol136.53K
Open1.12	D1 Closing1.10	Amplitude5.45%
Mkt Cap16.35M	Tradable Cap13.09M	Total Shares15.14M
T/O151.17K	T/O Rate1.13%	Tradable Shares12.12M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BCDA","market":"US","secType":"STK","nameCN":"BioCardia","latestPrice":1.08,"timestamp":1789156800000,"preClose":1.1,"halted":0,"volume":136530,"hourTrading":{"tag":"盘后","latestPrice":1.06,"preClose":1.08,"latestTime":"16:30 EDT","volume":10,"amount":10.780000999999999,"timestamp":1789158635809,"change":-0.02,"changeRate":-0.018519,"amplitude":0.018519},"delay":0,"changeRate":-0.018181818181818195,"floatShares":12117398,"shares":15138782,"eps":-0.73929,"marketStatus":"Post-Mkt","change":-0.02,"latestTime":"09-11 16:45:14 EDT","open":1.12,"high":1.14,"low":1.08,"amount":151174.112229,"amplitude":0.054545,"askPrice":1.14,"askSize":100,"bidPrice":1.06,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.73929,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789171200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.1,"preHourTrading":{"tag":"盘前","latestPrice":1.11,"preClose":1.1,"latestTime":"09:29 EDT","volume":903,"amount":1021.9139028,"timestamp":1789133399066,"change":0.01,"changeRate":0.009091,"amplitude":0.045455},"postHourTrading":{"tag":"盘后","latestPrice":1.06,"preClose":1.08,"latestTime":"16:30 EDT","volume":10,"amount":10.780000999999999,"timestamp":1789158635809,"change":-0.02,"changeRate":-0.018519,"amplitude":0.018519},"volumeRatio":1.290227,"impliedVol":0.046,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BCDA","defaultTab":"news","newsList":[{"id":"2666937105","title":"BioCardia CEO Peter Altman Presents at H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666937105","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666937105?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:31","pubTimestamp":1789043498,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman presents at H.C. Wainwright Global Investment ConferenceBioCardia to present at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026, in New Yor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbGHcSK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BQXX3D17.EUR","LU0314104364.USD","LU2210149790.SGD","BCDF","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BKPKM429.USD","SG9999014005.SGD","NDAQ","SG9999014039.USD","BK4139","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","BK4112","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4588","BK4585","IE00BN0W2W23.USD","SG9999014021.USD","SG9999014013.SGD","BCDA","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665357122","title":"BioCardia CEO Peter Altman Buys 800 Shares for $872","url":"https://stock-news.laohu8.com/highlight/detail?id=2665357122","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665357122?lang=en_us&edition=fundamental","pubTime":"2026-09-05 09:31","pubTimestamp":1788571871,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman buys 800 shares for $872BioCardia President, CEO, director Peter Altman bought 800 common shares at USD 1.09 each.Altman’s direct holding rose to 381,985 BioCardia common sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260905:nNDL2X5RnK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia CEO Peter Altman Buys 800 Shares for $872","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706852","title":"BioCardia Price Target Maintained with a $25.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706852","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706852?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:02","pubTimestamp":1787587320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BCDA/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705192","title":"BioCardia: Advancing Regulatory Momentum in Helix Catheter and CardiAMP HF Programs Supports Buy Rating and Unchanged $25 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705192","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705192?lang=en_us&edition=fundamental","pubTime":"2026-08-24 23:55","pubTimestamp":1787586951,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on BioCardia today and set a price target of $25.00. Joseph Pantginis has given hi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/biocardia-advancing-regulatory-momentum-in-helix-catheter-and-cardiamp-hf-programs-supports-buy-rating-and-unchanged-25-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/biocardia-advancing-regulatory-momentum-in-helix-catheter-and-cardiamp-hf-programs-supports-buy-rating-and-unchanged-25-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCDA","HF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661775279","title":"BioCardia gets FDA confirmation of Helix meeting minutes","url":"https://stock-news.laohu8.com/highlight/detail?id=2661775279","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661775279?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:00","pubTimestamp":1787576434,"startTime":"0","endTime":"0","summary":"BioCardia (BCDA) announced receipt of FDA confirmation of the outcome of its pre-submission meeting on the Helix Transendocardial Delivery Catheter...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biocardia-gets-fda-confirmation-of-helix-meeting-minutes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biocardia-gets-fda-confirmation-of-helix-meeting-minutes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCDA","BK4588","BK4585","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279743","title":"BioCardia Advances Helix Catheter Toward De Novo Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279743","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279743?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:00","pubTimestamp":1787576416,"startTime":"0","endTime":"0","summary":"An update from BioCardia ( ($BCDA) ) is now available. On August 24, 2026, BioCardia announced that the U.S. Food and Drug Administration had confi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biocardia-advances-helix-catheter-toward-de-novo-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biocardia-advances-helix-catheter-toward-de-novo-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276715","title":"BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-on De Novo Pre-Submission for Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276715?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA4XLHLD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276711","title":"BioCardia - to Submit Follow-on Pre-Submission for Helix This Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276711?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA4XLHLD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290656","title":"BioCardia Receives Nasdaq Notice on Minimum Bid Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290656?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:59","pubTimestamp":1787345950,"startTime":"0","endTime":"0","summary":"BioCardia ( ($BCDA) ) has issued an update. On August 19, 2026, BioCardia disclosed that it had received a notice from Nasdaq after its common stoc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biocardia-receives-nasdaq-notice-on-minimum-bid-price?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biocardia-receives-nasdaq-notice-on-minimum-bid-price?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCLG","BK4139","BCDA","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661297731","title":"BioCardia Receives NASDAQ Notice for Trading Below $1 Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661297731","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661297731?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:35","pubTimestamp":1787344524,"startTime":"0","endTime":"0","summary":"BioCardia receives Nasdaq notice for trading below $1 minimum bid price requirementBioCardia received a Nasdaq notice on Aug. 19, 2026 for failing the $1 minimum bid price rule for 30 consecutive sess","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLbZlJq2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660849696","title":"BioCardia CEO Peter Altman Acquires 5,400 Common Shares Worth $5,022","url":"https://stock-news.laohu8.com/highlight/detail?id=2660849696","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660849696?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:14","pubTimestamp":1787069690,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman acquires 5,400 common shares worth $5,022BioCardia President and CEO Peter Altman reported a purchase of 5,400 common shares.The shares were bought at a weighted-average pri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL6YNrfv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia CEO Peter Altman Acquires 5,400 Common Shares Worth $5,022","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659048118","title":"Nasdaq Listing Risks: Potential Delisting Threatens Biocardia’s Market Access and Financial Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2659048118","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659048118?lang=en_us&edition=fundamental","pubTime":"2026-08-14 14:00","pubTimestamp":1786687248,"startTime":"0","endTime":"0","summary":"Biocardia (BCDA) has disclosed a new risk, in the Share Price & Shareholder Rights category. Biocardia’s reliance on Nasdaq listing exposes investo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nasdaq-listing-risks-potential-delisting-threatens-biocardias-market-access-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nasdaq-listing-risks-potential-delisting-threatens-biocardias-market-access-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCLG","NQmain","BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659980651","title":"BioCardia CEO Peter Altman Acquires Common Shares Worth $1,748 in Open Market Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2659980651","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659980651?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:43","pubTimestamp":1786657420,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman acquires common shares worth $1,748 in open market purchaseBioCardia President and CEO Peter Altman bought 1,900 common shares in an open-market purchase at USD 0.92 each.Al","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLF4h1p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia CEO Peter Altman Acquires Common Shares Worth $1,748 in Open Market Purchase","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659116221","title":"HeartBeam Q2 Loss Per Share Narrows; Co Lowers FY Net Operating Cash Outflow Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2659116221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659116221?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:12","pubTimestamp":1786651935,"startTime":"0","endTime":"0","summary":"HeartBeam Q2 loss per share narrows; co lowers FY net operating cash outflow guidanceOverviewU.S. cardiac device maker's Q2 net loss nearly flat yr/yr, loss per share narrowsCompany lowered expected f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A140:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAT","BK4139","BCDA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659886181","title":"BioCardia Earnings Call Highlights Regulatory Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2659886181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659886181?lang=en_us&edition=fundamental","pubTime":"2026-08-13 08:10","pubTimestamp":1786579819,"startTime":"0","endTime":"0","summary":"Biocardia (($BCDA)) has held its Q2 earnings call. Read on for the main highlights of the call. BioCardia’s latest earnings call struck a cautiousl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biocardia-earnings-call-highlights-regulatory-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biocardia-earnings-call-highlights-regulatory-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188054","title":"BioCardia Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188054","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188054?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:00","pubTimestamp":1786568450,"startTime":"0","endTime":"0","summary":"BioCardia Inc reports results for the quarter ended June 30 - Earnings SummaryBioCardia IncBCDA.OQreported a quarterly adjusted loss of 13 cents per share for the quarter ended June 30, higher than th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N449260:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900726","title":"Sera Prognostics Q2 Revenue Rises on Expanded Partnerships and Medicaid Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900726","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900726?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:28","pubTimestamp":1786566507,"startTime":"0","endTime":"0","summary":"Sera Prognostics Q2 revenue rises on expanded partnerships and Medicaid coverageOverviewUS pregnancy diagnostics firm's Q2 revenue rose yr/yr, driven by expanded partnerships and Medicaid coverageComp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44912X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z6F94.USD","QTRX","BK4585","IE00B64QTZ34.USD","BCDA","BK4588","LU0205194284.USD","LU0205193047.USD","IE0034390439.USD","LU2237957811.SGD","TECH","BK4539","SERA","BK4121","BK4139","LU2237957902.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900317","title":"BioCardia Q2 FY26 Net Loss Narrows to $1.61 Million; Cash Rises to $4.12 Million as of June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900317","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900317?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:13","pubTimestamp":1786565592,"startTime":"0","endTime":"0","summary":"BioCardia Q2 FY26 net loss narrows to $1.61 million; cash rises to $4.12 million as of June 30, 2026BioCardia posted a net loss of $1.61 million in Q2 2026, narrowing from $2.05 million a year earlier","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLNYSNc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BCDF","BK4585","IE00B3QW5Z07.USD","BK4139","LU2095319765.USD","IE00BN0W2V16.EUR","BCDA","BK4588","SG9999014005.SGD","SG9999014039.USD","SG9999014021.USD","LU2210150020.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","NDAQ","LU0314104364.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659072429","title":"BioCardia Q2 EPS $(0.13) Beats $(0.18) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659072429","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659072429?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:06","pubTimestamp":1786565208,"startTime":"0","endTime":"0","summary":"BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 67.5 percent increase over losses of $(0.40) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61157815/biocardia-q2-eps-0-13-beats-0-18-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia Q2 EPS $(0.13) Beats $(0.18) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659690723","title":"BioCardia, Inc. Q2 Net Income USD -1.613 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659690723","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659690723?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:06","pubTimestamp":1786565165,"startTime":"0","endTime":"0","summary":"BRIEF-BioCardia, Inc. Q2 Net Income USD -1.613 MillionAug 12 (Reuters) - BioCardia, Inc. Q2 operating income USD -1.623 million.Q2 basic EPS USD -0.13","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXLGPS2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biocardia.com","stockEarnings":[{"period":"1week","weight":0.0092},{"period":"1month","weight":0.1801},{"period":"3month","weight":0.25},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.4811},{"period":"ytd","weight":-0.12}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0165},{"period":"3month","weight":0.0217},{"period":"6month","weight":0.1443},{"period":"1year","weight":0.1619},{"period":"ytd","weight":0.1113}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.066663},{"month":2,"riseRate":0.5,"avgChangeRate":-0.017269},{"month":3,"riseRate":0.25,"avgChangeRate":-0.022375},{"month":4,"riseRate":0.375,"avgChangeRate":0.007226},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.09523},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.005776},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.051846},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.048777},{"month":9,"riseRate":0.333333,"avgChangeRate":0.003908},{"month":10,"riseRate":0.375,"avgChangeRate":-0.049332},{"month":11,"riseRate":0.5,"avgChangeRate":0.042585},{"month":12,"riseRate":0.375,"avgChangeRate":-0.012187}],"exchange":"NASDAQ","name":"BioCardia","nameEN":"BioCardia"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioCardia(BCDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BioCardia(BCDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BioCardia,BCDA,BioCardia股票,BioCardia股票老虎,BioCardia股票老虎国际,BioCardia行情,BioCardia股票行情,BioCardia股价,BioCardia股市,BioCardia股票价格,BioCardia股票交易,BioCardia股票购买,BioCardia股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioCardia(BCDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BioCardia(BCDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}